Abbott Labs (ABT) is up $1.35 to $46.68 on news the company is acquiring the pharmaceutical biz of Belgium’s Solvay. ABT options volume is running 4X the average daily, with 38K calls and 22K puts traded so far. Trading is scattered across a variety of contracts and, while shares are higher, sentiment in the options market seems mixed. Oct 49 calls are the most actives and hitting 61 percent on the bid. Meanwhile, Jan10 45 puts are the second most actives, with 69 percent trading ask-side. Implied volatility average (average) in ABT is not much changed at 21 (-.2), compared to a 52-week high and low of 60 and 20.4.
About the Author (Author Profile)
Frederic Ruffy is a well-known trader, writer, and strategist who has spent years educating investors and creating intelligent, insightful, unbiased market observations that are frequently cited by the Wall Street Journal and other financial publications. As senior analyst, Fred provides frequent and regular notes and daily updates for activity of interest.